Condition

Ganglioneuroblastoma clinical trials and research

• 6Clinical trials
• 9Countries

Newest Ganglioneuroblastoma clinical trials

All recruiting trials (6)

• Dual-target GD2 and B7-H3 CAR-NK therapy for children and young adults with relapsed or refractory neuroblastoma

  This trial tries an off-the-shelf CAR-NK cell treatment that targets GD2 and B7-H3 for children and young adults whose high-risk neuroblastoma has returned or not responded to prior therapy.

  Recruiting Phase 1/2 Beijing Biotech · Shenzhen, Guangdong · NCT07502287

• Chemoimmunotherapy with autologous NK‑cell therapy for children with refractory or relapsed high‑risk neuroblastoma and ganglioneuroblastoma

  This treatment will test whether adding a child's own expanded natural killer (NK) cells to chemoimmunotherapy helps children with refractory or relapsed high‑risk neuroblastoma or ganglioneuroblastoma respond better.

  Recruiting Phase 3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT07375563

• Assessing surgical risk factors for laparoscopic surgery in abdominal neuroblastoma

  This study is trying to see how different factors affect the safety and success of laparoscopic surgery for children with abdominal neuroblastoma.

  Recruiting Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT06296732

• Induction chemotherapy combined with immunotherapy for high-risk neuroblastoma

  This study is testing a new treatment that combines chemotherapy with immunotherapy to see if it helps children and teens with high-risk neuroblastoma do better and live longer.

  Recruiting Phase 3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT06071897

• International registry and biobank for patients with peripheral neuroblastic tumors

  This study is setting up a global database and biobank for patients with peripheral neuroblastic tumors to gather important health information and samples that can help improve future treatments.

  Recruiting at 35 sites Institut Curie · Prague and 37 other locations · NCT05192980

• Adding iobenguane I-131 or lorlatinib to intensive treatment for children and young adults with high-risk neuroblastoma

  This trial tests whether adding the radioactive drug iobenguane I-131 or the targeted drug lorlatinib to standard intensive therapy helps children and young adults with newly diagnosed high-risk neuroblastoma or nodular ganglioneuroblastoma stay free of disease longer.

  Recruiting at 153 sites Phase 3 Children's Oncology Group · Birmingham, Alabama and 163 other locations · NCT03126916

Related topics

Quick answers

How many Ganglioneuroblastoma clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in Russia (3 trials), Canada (1 trial), Puerto Rico (1 trial), United States (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →